Speakers

Featured Speakers

Anthony Atala, M.D.
Senior Researcher and Director, Institute for Regenerative Medicine
Wake Forest University School of Medicine

Senator Thomas A. Daschle
Former United States Senator and Special Public Policy Advisor, Alston & Bird

Tony Hickson BSc, MBA
Head of Biosciences, Imperial Innovations Ltd.

Featured Plenary Session Speakers

Moderator

• Vipin Garg, Ph.D., President & Chief Executive Officer, Tranzyme Pharma

Speakers

• Om P. Dhingra, Ph.D., Vice President & Head, Preclinical Drug Discovery, GlaxoSmithKline
• Pierre Gosselin Ph.D., Director Business Development, Shire Pharmaceuticals, Inc.
• Knut Sturmhoefel, Head, Search & Evaluation, Novartis Pharma AG
• Mike Ward, Senior Editor, Europe, BioCentury Publications
• Andrew Weisenfeld, Managing Director, Healthcare Corporate Investment Banking, Banc of America Securities LLC

Panel Session and Strategic Forum Speakers

• Andrew Balber, Ph.D., Vice President, Preclinical Development, Aldagen
• George Briggs, Executive Director, North Carolina Arboretum
• Scott Burger, MD, Principal, Advanced Cell & Gene Therapy
• Steven Burke, Senior Vice President of Corporate Affairs, North Carolina Biotechnology Center
• Thomas Carter, Partner, Alston & Bird LLP
• Greg Cumberford, Vice President, Strategic Initiatives, Gaia Herbs, Inc.
• Amy Ehlers, Manager, Industry and Environmental Section, Biotechnology Industrial Organization
• Joel Eisner, Ph.D., Associate Principal, Cato BioVentures
• Lyle Estill, Vice President, Piedmont Biofuels
• Mark Furth, Ph.D., Technical Development Officer, Wake Forest University Institute for Regenerative Medicine
• Michael Gaito, Managing Director, J.P. Morgan Healthcare Investment Banking
• Vipin Garg, Ph.D., President & Chief Executive Officer, Tranzyme Pharma
• Steve Kelley, Ph.D., Chair, Department of Wood and Paper Science, North Carolina State University
• Garheng Kong, M.D., Ph.D., Partner, Intersouth Partners
• Edward May, Associate, US Renewables Group
• Robert McMahan, Ph.D., Senior Advisor to the Governor for Science & Technology and Executive Director, NC Board of Science and Technology
• Cheryl McMurry, Director, Western Office, North Carolina Biotechnology Center
• George Montgomery, Managing Directory and Head of Healthcare Banking, Montgomery & Co., LLC
• Jonathan Moreno, Ph.D., Professor of Medical Ethics, University of Pennsylvania
• Thomas Nagy, President, Novozymes North America, Inc.
• Roger Nolan, Director, Project Operations, Calvert Research Institute
• Nick Oberlies, Ph.D., Director, Natural Products Laboratory, Research Triangle Insititute
• David Ohashi, Ph.D., Duplin Winery and Lead Resveratrol Developer
• Cedric Pearce, Ph.D., Chief Executive Officer, Mycosynthetix, Inc.
• Daniel A. Pelak, President & Chief Executive Officer, InnerPulse, Inc.
• Sharon Presnell, Ph.D., Vice President for Regenerative Medicine and Biology, Tengion, Inc.
• Maria Rapoza, Ph.D., Vice President of Science and Technology, North Carolina Biotechnology Center
• Michael Recny, Ph.D.
• Terry Ruse, Chief Operating Officer, Agri Ethanol Products LLC
• Jeffrey D. Schmitt, Ph.D., Acting Research Director, International Institute for Natural Biotechnology and Integrative Medicine
• Garrett Screws, Senior Manager of Governmental Relations, Novozymes
• The Honorable Norris Tolson, Secretary of Revenue, State of North Carolina
• Edward Torres, Managing Director, Lilly Ventures
• Steve Tregay, Ph.D., Managing Director, Novartis Option Fund
• Ivan Urlaub, Executive Director, North Carolina Sustainable Energy Association
• Simon Warner, Ph.D., Group Leader for Biomass Traits, Syngenta
• Richard West, Chief Executive Officer, Advanced Liquid Logic, Inc.
• David Winwood, Ph.D., Associate Vice Chancellor, Technology Development and Innovation, North Carolina State University

Meet engaging speakers during one of the many interactive panel sessions the conference offers. Check back regularly for speaker additions.

Visit the Biotech 2006 Web site to see last year’s top-notch speakers.